|
AUPQ080999A0
|
|
Method of treatment
|
|
AU9147298A
|
|
Diagnostic method for detecting soluble cd48
|
|
AUPP234398A0
|
|
Method of treatment of granulosa cell tumors
|
|
AUPP106997A0
|
|
Selection/amplification procedure
|
|
AUPP086497A0
|
|
Method of producing recombinant protein
|
|
AUPO933597A0
|
|
Diagnostic method
|
|
AU2143597A
|
|
The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
|
|
CA2249998A1
|
|
The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
|
|
AUPO245596A0
|
|
Diagnostic method
|
|
AUPO029096A0
|
|
Npy y2 agonists
|
|
AUPN903596A0
|
|
The use of antibodies against CD48 for the treatment T and B cell lymphomas and leukemias
|
|
AUPN896296A0
|
|
The use of antibodies against cd48 for the treatment t and b cell lymphomas and leukemias
|
|
AU3864795A
|
|
Fusion proteins with cytotoxic activity against cells overexpressing erbB2-4
|
|
AUPN523995A0
|
|
Method for producing phage display vectors
|
|
AUPN238695A0
|
|
Phage display vector
|
|
AUPM959894A0
|
|
Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4
|
|
US5696093A
|
|
Method of treating nasal congestion using neuropeptide Y Y2 agonist peptides
|
